rs7275

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003072.5(SMARCA4):​c.4887T>C​(p.Asp1629Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.296 in 1,551,084 control chromosomes in the GnomAD database, including 69,913 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6233 hom., cov: 33)
Exomes 𝑓: 0.30 ( 63680 hom. )

Consequence

SMARCA4
NM_003072.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -3.51

Publications

38 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • otosclerosis
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 19-11060163-T-C is Benign according to our data. Variant chr19-11060163-T-C is described in ClinVar as Benign. ClinVar VariationId is 126365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.51 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.317 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003072.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
NM_001387283.1
MANE Plus Clinical
c.4983T>Cp.Asp1661Asp
synonymous
Exon 35 of 36NP_001374212.1Q9HBD4
SMARCA4
NM_003072.5
MANE Select
c.4887T>Cp.Asp1629Asp
synonymous
Exon 34 of 35NP_003063.2
SMARCA4
NM_001128849.3
c.4983T>Cp.Asp1661Asp
synonymous
Exon 35 of 36NP_001122321.1Q9HBD4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
ENST00000646693.2
MANE Plus Clinical
c.4983T>Cp.Asp1661Asp
synonymous
Exon 35 of 36ENSP00000495368.1Q9HBD4
SMARCA4
ENST00000344626.10
TSL:1 MANE Select
c.4887T>Cp.Asp1629Asp
synonymous
Exon 34 of 35ENSP00000343896.4P51532-1
SMARCA4
ENST00000643549.1
c.4893T>Cp.Asp1631Asp
synonymous
Exon 34 of 35ENSP00000493975.1A0A2R8Y4P4

Frequencies

GnomAD3 genomes
AF:
0.281
AC:
42769
AN:
152018
Hom.:
6231
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.303
Gnomad AMI
AF:
0.344
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.259
Gnomad EAS
AF:
0.0912
Gnomad SAS
AF:
0.332
Gnomad FIN
AF:
0.231
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.303
Gnomad OTH
AF:
0.265
GnomAD2 exomes
AF:
0.261
AC:
40606
AN:
155306
AF XY:
0.271
show subpopulations
Gnomad AFR exome
AF:
0.300
Gnomad AMR exome
AF:
0.163
Gnomad ASJ exome
AF:
0.249
Gnomad EAS exome
AF:
0.0819
Gnomad FIN exome
AF:
0.231
Gnomad NFE exome
AF:
0.303
Gnomad OTH exome
AF:
0.280
GnomAD4 exome
AF:
0.297
AC:
416170
AN:
1398948
Hom.:
63680
Cov.:
38
AF XY:
0.299
AC XY:
206524
AN XY:
690000
show subpopulations
African (AFR)
AF:
0.300
AC:
9464
AN:
31580
American (AMR)
AF:
0.167
AC:
5951
AN:
35698
Ashkenazi Jewish (ASJ)
AF:
0.254
AC:
6393
AN:
25170
East Asian (EAS)
AF:
0.0895
AC:
3198
AN:
35732
South Asian (SAS)
AF:
0.347
AC:
27510
AN:
79216
European-Finnish (FIN)
AF:
0.233
AC:
11462
AN:
49182
Middle Eastern (MID)
AF:
0.298
AC:
1667
AN:
5588
European-Non Finnish (NFE)
AF:
0.309
AC:
333615
AN:
1078814
Other (OTH)
AF:
0.292
AC:
16910
AN:
57968
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
18797
37594
56392
75189
93986
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11130
22260
33390
44520
55650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.281
AC:
42797
AN:
152136
Hom.:
6233
Cov.:
33
AF XY:
0.276
AC XY:
20553
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.303
AC:
12584
AN:
41510
American (AMR)
AF:
0.213
AC:
3264
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.259
AC:
898
AN:
3472
East Asian (EAS)
AF:
0.0912
AC:
471
AN:
5166
South Asian (SAS)
AF:
0.330
AC:
1593
AN:
4820
European-Finnish (FIN)
AF:
0.231
AC:
2443
AN:
10584
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.303
AC:
20609
AN:
67978
Other (OTH)
AF:
0.264
AC:
556
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1624
3248
4872
6496
8120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
452
904
1356
1808
2260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.292
Hom.:
18668
Bravo
AF:
0.279
Asia WGS
AF:
0.224
AC:
782
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
1
Coffin-Siris syndrome (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Intellectual disability, autosomal dominant 16 (1)
-
-
1
not provided (1)
-
-
1
Rhabdoid tumor predisposition syndrome 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.13
DANN
Benign
0.54
PhyloP100
-3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7275; hg19: chr19-11170839; COSMIC: COSV60786038; COSMIC: COSV60786038; API